Patents Assigned to BioCell Technology, LLC
  • Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
    Patent number: 8563045
    Abstract: Hydrolyzed collagen type II powder compositions for inducing cartilage formation in an individual, method of preparing the compositions and use of the compositions in treating connective tissue disorder, replenishing skin viscoelasticity. The compositions are administered through an orally ingestible delivery medium for absorption into the gastrointestinal tract. The compositions are administered through a topical delivery medium for absorption into a dermis of the individual.
    Type: Grant
    Filed: September 13, 2010
    Date of Patent: October 22, 2013
    Assignee: Biocell Technology, LLC
    Inventor: Suhail Ishaq
  • Hyaluronic Acid and Chondroitin Sulfate Based Hydrolyzed Collagen Type II and Method of Making Same
    Publication number: 20110034392
    Abstract: Hydrolyzed collagen type II powder compositions for inducing cartilage formation in an individual, method of preparing the compositions and use of the compositions in treating connective tissue disorder, replenishing skin viscoelasticity. The compositions are administered through an orally ingestible delivery medium for absorption into the gastrointestinal tract. The compositions are administered through a topical delivery medium for absorption into a dermis of the individual.
    Type: Application
    Filed: September 13, 2010
    Publication date: February 10, 2011
    Applicant: BIOCELL TECHNOLOGY, LLC
    Inventor: Suhail Ishaq
  • Therapeutic composition comprising hyaluronic acid and chondroitin sulfate and method of making same
    Patent number: 7799348
    Abstract: Hydrolyzed collagen type II powder compositions for inducing cartilage formation in an individual, method of preparing the compositions and use of the compositions in treating connective tissue disorder, replenishing skin viscoelasticity. The compositions are administered through an orally ingestible delivery medium for absorption into the gastrointestinal tract. The compositions are administered through a topical delivery medium for absorption into a dermis of the individual.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: September 21, 2010
    Assignee: BioCell Technology, LLC
    Inventor: Suhail Ishaq
  • Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
    Patent number: 6780841
    Abstract: Hydrolyzed collagen type II powder compositions for inducing cartilage formation in an individual, method of preparing the compositions and use of the compositions in treating connective tissue disorder, replenishing skin viscoelasticity. The compositions are administered through an orally ingestible delivery medium for absorption into the gastrointestinal tract. The compositions are administered through a topical delivery medium for absorption into a dermis of the individual.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: August 24, 2004
    Assignee: BioCell Technology, LLC
    Inventor: Suhail Ishaq
  • Hydrolyzed collagen type II and use thereof
    Patent number: 6025327
    Abstract: Hydrolyzed collagen type II powder compositions, method of preparing the compositions and use of the compositions in treating cartilage defects. The compositions are orally administered to an individual in need of cartilage augmentation in a daily dosage of between about 2,000 and 3,000 mg per day.
    Type: Grant
    Filed: August 8, 1997
    Date of Patent: February 15, 2000
    Assignee: Biocell Technology, LLC
    Inventor: Ahmed Alkayali
  • Anionic saccharides for extraction of anti-angiogenic protein from cartilage
    Patent number: 5843920
    Abstract: Anti-angiogenic protein composition can be prepared simply and efficiently by contacting cartilage particles containing the protein together with an electrolyte solution and an oligosaccharide bearing a minimum number of anionic substituents per sugar unit, to extract the anti-angiogenic protein from the cartilage particles and to form a complex of the oligosaccharide and the protein. The resultant anti-angiogenic complex can be used for therapeutic treatment of various angiogenic and related diseases.
    Type: Grant
    Filed: September 16, 1996
    Date of Patent: December 1, 1998
    Assignee: BioCell Technology, LLC
    Inventor: Paul B. Weisz